The Varilix vaccine is designed to prevent chickenpox infection. It contains a live, weakened virus that stimulates the immune system to produce antibodies that prevent future infection. This vaccine is highly effective, especially when given to children at an early age before exposure to the virus. It can also be used for adults who have not previously had the disease and have not received the vaccination. The vaccine helps reduce the severity of symptoms if infection occurs after vaccination, thus reducing potential complications.
Varilix is administered by subcutaneous injection. The number of doses and the frequency of administration are determined by the doctor based on the individual's age and health status. After vaccination, the individual may experience some minor symptoms, such as redness or swelling at the injection site or a slight fever. These symptoms are temporary and resolve spontaneously. It is important to adhere to the prescribed vaccination schedule to ensure maximum protection against chickenpox and limit its spread in the community.